Do you know cancer when you see it? Not everything you think may be cancer on final pathology. Read more in this month’s issue of DISEASES OF THE COLON AND RECTUM.
“All surgeons must assess what is malignant and what is not on a daily basis. Yet, how accurate surgeons are in identifying carcinoma intraoperatively is not as well quantified in the literature as one would expect,” said Edward A. Levine, MD, in a recent editorial published is DISEASES OF THE COLON AND RECTUM (Dis Colon Rectum 2021;64:501-503). In this editorial, readers are referred to an international study by Bhatt and colleages evaluating how accurate surgeons were in identifying cancer in patients undergoing cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC).
Citations:
1. Levine EA. Do you know cancer when you see it? Dis Colon Rectum 2021;64:501-503. (Link to editorial: https://journals.lww.com/dcrjournal/Fulltext/2021/05000/Do_You_Know_Cancer_When_You_See_It_.1.aspx)
2. Bhatt A, Benzerdjeb N, Passot G, et al. Implications of pathologic findings in cytoreductive surgery specimens on treatment of colorectal peritoneal metastases: results of a prospective mutlicentric study. Dis Colon Rectum 2021;64:534-544. (Link to study: https://journals.lww.com/dcrjournal/Fulltext/2021/05000/Implications_of_Pathologic_Findings_in.7.aspx)
